News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3129last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
24/7 Wall St.50d agoneutral
Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story?Simply Wall St.51d agoneutral
Amgen (AMGN) Stock Sees Modest Fair Value Lift As Analysts Weigh Pipeline RisksInsider Monkey52d agoneutral
A Failed Cholesterol Drug Raises the Stakes for Amgen (AMGN) and Eli Lilly (LLY) TooBarrons.com53d agoneutral
Will AI Save the Pharma Industry Billions? Novo’s Anthropic Deal Is Betting on It.MarketBeat54d agoneutral
Amgen Highlights MariTide, IMDELLTRA Pipeline Progress and Growth PrioritiesMotley Fool55d agobullish
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?Insider Monkey56d agoneutral
Amgen (AMGN) Fell 5% on a Drug That Isn’t Even Its Own. Here’s the Lp(a) Bet Now in Question.The Wall Street Journal57d agoneutral
Heart Disease, a Historic Strength for Big Pharma, Becomes a WeaknessMarketBeat58d agoneutral
Amgen Highlights 26% Growth Drivers, IMDELLTRA Momentum and MariTide Potential